Prevalence of Chlamydia trachomatis and herpes simplex virus 2 in cervical carcinoma associated with human papillomavirus detected in paraffin-sectioned samples

European Journal of Gynaecological Oncology

Volumn 30, Issue 1, 2009, Pages 65-70

  Kwaśniewska, Anna ^a,c   Korobowicz, E ^a   Zdunek, M ^a   Skoczynski M ^a   Kwasniewski W ^a   Danilos J ^a   Gozdzicka Jozefiak A ^b  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b ADAM MICKIEWICZ UNIVERSITY   (Poland)

^c Department of Gynecological Oncology and Gynecology Medical University of Lublin ^*  (Poland)

Author keywords

Cervical carcinoma; Chlamydia trachomatis; Herpes virus; HPV; HSV 2

Indexed keywords

BACTERIAL DNA; VIRUS DNA;

ADENOCARCINOMA; ADULT; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA ISOLATION; FEMALE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; MIXED INFECTION; NONHUMAN; PRECANCER; TISSUE SECTION; UTERINE CERVIX CARCINOMA; VIRUS IDENTIFICATION; VIRUS INFECTION; WART VIRUS;

ADENOCARCINOMA; ADULT; ALPHAPAPILLOMAVIRUS; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; POLAND; PREVALENCE; UTERINE CERVICAL NEOPLASMS;

EID: 60749110365     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Bosch D.X., Lorincz A., Munoz N., Meijer C.J., Shah K.V.: "The causal relation between human papillomavirus and cervical cancer". J. Clin. Pathol., 2002, 55, 244.
2. zur Hausen H.: "Papillomaviruses and cancer: from basic studies to clinical application". Nature Rev., 2002, 2, 342.
3. Schiffman M., Castle P.E.: "Human papillomavirus". Arch. Pathol. Lab. Med., 2003, 127, 930.
4. Finan R.R., Tamim H., Almawi W.Y.: "Identification of C. trachomatis DNA in human papillomavirus (HPV) positive women with normal and abnormal cytology". Arch. Gynecol. Obstet., 2002, 266, 168.
5. Schlott T., Eiffert H., Bohne W., Landgrebe J., Brunner E., Spielbauer B., Knight B.: "C. trachomatis modulates expression of tumor supressor gene caveolin-1 and oncogenen C-myc in the transformation zone of non-neoplastic cervical tissue". Gynecol. Oncol., 2005, 98, 409.
6. Jha P.K., Beral V., Peto J., Hack S., Hermon C., Deacon J. et al.: "Antibodes to human papillomavirus and the other genital infections agents and invasive cervical cancer risk". Lancet, 1993, 341, 47.
7. Anttila T., Saikku P., Koskela P., Bloigu A., Dillner J., Ikaheimo I. et al.: "Scrotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma". JAMA, 2001, 285, 47.
8. Dillner J., Lenner P., Lehtinen M., Eklund C., Heino P., Wiklund F. et al.: "A population-based seroepidemiological study of cervical cancer". Cancer Res., 1999, 54, 134.
9. Lehtinen M., Dillner J., Knekt P., Luoastarinen T., Aromaa A., Kirnabauer R. et al.: "Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma". Br. Med. J., 1996, 312, 537.
10. Koskela P., Antila T., Bjoerge T., Brunsvig A., Dilner J., Hakam M. et al.: "Chlamydia trachomatis infection as a risk factor for invasive cervical cancer". Int. J. Cancer, 2000, 85, 35.
11. Wallin K.L., Wiklund F., Loustarinen T., Antila T., Bergman F., Hallmans G. et al.: "A population based prospective study of C. trachomatis infection and cervical carcinoma". Int. J. Cancer, 2002, 101, 371.
12. Smith J.S., Herrero R., Bosetti C., Munoz N., Bosch F.X., Eluf-Neto J. et al.: "Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer". J. Natl. Cancer Inst., 2002, 94, 1604.
13. Lehtinen M., Koskela P., Jellum E., Bloigu A., Antilla T., Hallmans G. et al.: "Herpes simplex virus and risk of cervical cancer: a longitudinal, nested case-control study in the nordic countries". Am. J. Epidemiol., 2002, 156, 687.
14. Castle P.E., Escoffery C., Schachter J., Rattray C., Schiffman M., Moncoda J. et al.: "C. trachomatis, Herpes simplex virus 2, and human T-cell lymphotrophic virus type 1 are not associated with grade of cervical neoplasia in Jamican colposcopy patients". Sex. Transm. Dis., 2003, 30, 575.
15. Eberhart-Phillips J., Dickson N.P., Paul C., Fawcett J.P., Holland D., Taylor J.: "Herpes simplex type 2 infection in a cohort aged 21 years". Sex. Transm. Infect., 1998, 74, 216.
16. Austin H., Macalusso M., Nahmias A., Lee F.K., Kelaghan J., Fleenor M.V: "Correlates of herpes simplex virus seroprevalence among women attending a sexually transmitted disease clinic". Sex. Transm. Dis., 1999, 26, 329.
17. Scully R.E., Bonfiglio T.A., Kurman R.J., Silverberg G., Wilkinson E.J.: "WHO international classification of tumors: histological typing of female genital tract tumors". New York, Springer-Verlag, 1996.
18. Creasman W.T.: "Announcement, FIGO stages, 1988 revision". Gynecol. Oncol., 1989, 35, 125.
19. Tucker R.A., Johnson P.R., Reeves W.: "Using the polymerase chain reaction to genotype human papillomavirus DNAs in samples containing multiple HPVs may produce inaccurate results". J. Virol. Methods, 1993, 43, 321.
20. Franceschi S.: "The IRAC commitment to cancer prevention: the example of papillomavirus and cervical cancer". Recent Results Cancer Res., 2005, 166, 277.
21. Gilson R.J.C., Mindel A.: "Sexually transmitted infection". Br. Med. J., 2001, 322, 1160.
22. Centers for Disease Control and Prevention: "Sexually transmitted diseases survivallance 2000 supplement: Chlamydia prevalence monitoring project". Atlanta, GA, Department of Health and Human Services, 2001.
23. World Health Organization: "Global prevalence and incidence of selected curable sexual transmitted infections; overview and estimates". Geneva, WHO, 2001.
24. Markowska J.: "C. trachomatis a stany przedrakowe i rak szyjki macicy". Koloskopia, 2001, 1, 42.
25. Schlott T., Ruda D., Hoppert M., Nagel H., Reimer S., Schimacher-Lutage I.K.: "The in situ polymerase chain reaction for detection of chlamydia trachomatis". J. Histoch. Cytoch., 1998, 46, 1017.
26. Smith J.S., Bosetti C., Munoz N., Herrero R., Bosch X., Eluf-Neto J. et al.: "C. trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study". Int. J. Cancer, 2004, 111, 431.
27. Dillner J., Lehtinen M., Bjorge T., Luostarinen T., Youngman, Jellum E. et al.: "Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer". J. Natl. Cancer Inst., 1997, 89, 1293.
28. van den Brule F.: "Vaginal infections and sexually transmitted diseases". Rev. Med. Liege, 1999, 54, 296.
29. Moscicki A.B., Hills N.K., Shiboski S., Palefsky J.M.: "Risk for incident high grade squamous intraepitehelial lesions (HSIL) among adolescent and young women". 18th International HPV Conference. Barcelona, 2000.
30. Molano M., Weiderpass E., Posse, H., Morre S.A., Ronderos M., Franceschi S. et al.: "Prevalence and determinants of C. trachomatis infection in women from Bogota, Colambia". Sex. Transm. Dis., 2003, 79, 474.
31. Yang Y.Y., Koh W., Tsai H., Wong E.F., Lin S.J., Yang C.C.: "Correlation of viral factors with cervical cancer in Taiwan". J. Microbiol. Immunol. Infect., 2004, 37, 282.
32. Fan T., Lu H., Hu H., Shi L., McClarty G.A., Nance D.M. et al.: "Inhibition of apoptosis in chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation". J. Exp. Medicine, 1998, 187, 487.
33. Rosin M.P., Anwar W.A., Ward A.J.: "Inflammation, chromosomal instability, and cancer: the schistosomiasis model". Cancer Res., 1994, 54, 1929.
34. Drago F., Rebora A.: "Human herpes virus as a sexually transmitted agent". Lancet, 2001, 357, 307.
35. Schmitt J., Schlehofer J.R., Mergener K., Gissmann L., zur Hansen H.: "Amplification of bovine papillomavirus DNA by N-methyl-n'-nitro-nitrosoquanidine, ultraviolet irradiation, or infection with herpes simplex virus". Virology, 1989, 172, 73.
36. Merino M.J.: "Vaginal cancer; the role of infectious and environmental factors". Am. J. Obstet. Gynecol., 1991, 165, 1255.
37. Yamakawa Y., Forslund O., Chua K.L., Dillner L., Boon M.E., Hansson B.G.: "Detection of the BC24 transforming fragment of the herpes simplex virus type 2 (HSV-2) DNA in cervical carcinoma tissue by polymerase chain reaction (PCR)". APMIS, 1994, 102,401.
38. DiPaolo J.A., Woodworth C.D., Popescu N.C., Koval D.L., Lopez J.V., Doniger J.: "HSV-2 induced tumorigenicity in HPV16-immortalized genital keratynocytes". Virology, 1990, 177, 777.
39. Meyers C., Andreansky S.S., Courtney R.J.: "Repication and interaction of herpes simplex virus and human papillomavirus in differenting host epitehelial tissue". Virology, 2003, 315, 43.
40. Pisani S., Imperi M., Segariti L., Superti F., Tinari A., Bucci M., Degener A.M.: "Effect of HSV-2 infection on the expression of HPV 16 genes in CaSki cells". Int. J. Immunopathol. Pharmacol., 2004, 17, 65.